Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Observational Cohort Study of Patients With Newly Diagnosed Unresectable Stage IIIB, IIIC, or IV Non-Small-Cell Lung Cancer (NSCLC) in China

NCT05872763 is registered in ClinicalTrials.gov with Hoffmann-La Roche as lead sponsor.

NCT NCT05872763
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05872763 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Observational Cohort Study of Patients With Newly Diagnosed Unresectable Stage IIIB, IIIC, or IV Non-Small-Cell Lung Cancer (NSCLC) in China
Lead sponsor
Hoffmann-La Roche
Phase
Observational
Overall status
Completed
Start date
August 11, 2023
Completion date
March 18, 2026
Enrollment
901 (actual)
Sites
12

Conditions

As the registry lists them; a condition with its own page is linked.

carcinoma, non-small-cell lung